Cargando…
Inhibition of human platelet phospholipase A2 by mono(2-ethylhexyl)phthalate.
There is evidence that the carcinogenic and teratogenic effects attributed to the plasticizer di(2-ethylhexyl)phthalate (DEHP) are due to its major metabolite mono(2-ethylhexyl)phthalate (MEHP). MEHP is also formed ex vivo by a plasma enzyme in blood products stored in polyvinyl chloride (PVC) DEHP...
Autores principales: | Labow, R S, Meek, E, Adams, G A, Rock, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1474597/ https://www.ncbi.nlm.nih.gov/pubmed/3203637 |
Ejemplares similares
-
Distribution of di(2-ethylhexyl) phthalate and products in blood and blood components.
por: Rock, G, et al.
Publicado: (1986) -
The effect of mono(2-ethylhexyl)phthalate on an isolated perfused rat heart-lung preparation.
por: Labow, R S, et al.
Publicado: (1990) -
The in vitro serum protein-binding characteristics of bis-(2-ethylhexyl) phthalate and its principal metabolite, mono-(2-ethylhexyl) phthalate.
por: Griffiths, W C, et al.
Publicado: (1988) -
Fetotoxic effects of mono-2-ethylhexyl phthalate (MEHP) in mice.
por: Tomita, I, et al.
Publicado: (1986) -
Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate.
por: Kato, Kayoko, et al.
Publicado: (2004)